Invention Grant
- Patent Title: Targeting of MKRN1 for identifying cancer treatment agents
- Patent Title (中): 靶向MKRN1用于鉴定癌症治疗剂
-
Application No.: US11279151Application Date: 2006-04-10
-
Publication No.: US07901906B2Publication Date: 2011-03-08
- Inventor: Mark T. Muller , In Kwon Chung
- Applicant: Mark T. Muller , In Kwon Chung
- Applicant Address: US FL Orlando
- Assignee: University of Central Florida Research Foundation, Inc.
- Current Assignee: University of Central Florida Research Foundation, Inc.
- Current Assignee Address: US FL Orlando
- Agency: Beusse Wolter Sanks Mora & Maire
- Agent Timothy H. Van Dyke
- Main IPC: C12N15/00
- IPC: C12N15/00
Abstract:
Disclosed herein are novel methods for screening for compounds useful in treating telomerase positive cancers. In exemplary embodiments, screening methods are based on the implementation or manipulation of therapeutic agents that up-regulate activity or expression of MKRN polypeptides or polynucleotides encoding the same, respectively. The methods are useful in identifying agents that can serve as cancer therapeutic agents.
Public/Granted literature
- US20070224199A1 Targeting of MKRN1 for Identifying Cancer Treatment Agents Public/Granted day:2007-09-27
Information query
IPC分类:
